Medicines are failing on malaria-causing mosquitoes

Highlights

• About 80 percent of malaria parasites have become drug registrars in some areas of Southeast Asia.
• Artemisinin and Piparicin medicines given for malaria are failing
• Doctors have to give drugs other than these medicines for treatment.
• Experts have described the formation of a parasitic drug regulator as a threat to malaria prevention.

Malaria consumed by millions of people every year and can take dangerous form. According to two studies published in the journal ‘The Lancet’, about 80 percent of malaria parasites have developed drug-resistant capacities in South-East Asia and are spreading rapidly. These parasites spread from Cambodia to Laos and Thailand in Vietnam. On half of the patients who have been subjected to these, artificial insulin and Piparicin medicines have failed, which are given for the treatment of malaria. 

The most deadly parasite responsible for spreading malaria in humans is becoming a drug-resistant to Plasmodium falciparum, which is believed to be a major threat to prevent this disease. This parasite is responsible for 9 out of 10 deaths due to malaria.

According to a researcher linked to the study, Plasmodium falciparum, which became a drug resistor, is replacing other local malaria parasites, due to which it is making the treatment process complicated. 

In the second study published in the journal, it was clarified that the treatment of malaria is possible even after being a drug resident. However, due to drug-resistant capabilities, patients suffering from malaria will have to give other medicines apart from artificial insemination and piperaquine. 

Experts believe that in view of the ability to disperse the parasite’s quality, there is a dire need to make changes in the treatment of malaria drugs or changes in the treatment method.